Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Comment by GiveMeMoneyon Oct 29, 2020 3:15pm
100 Views
Post# 31807198

RE:RE:RE:Know your facts about the market place and your product.

RE:RE:RE:Know your facts about the market place and your product.Q 1: Well, if you give me a year head start like we all gave CRDL, it will probably be on pharamies and grocery store shelves.

Q 2: CBD is not Coke-a-Cola, it's form can't be patented since it's not 'a mix': it's either CBD pure or not. Consquently, as I mentioned before, "We'll let CRDL make the market for both with its brand name, for both, and then take it all away from them once it's established: the story with all drugs. And I bet my costs are cheaper than CRDL's by a long shot!" The Story of Apotex etc. etc.

Q 3: In time, like maybe a year since that is what was given to CRDL, probably materially less. You feel out Biovectra yourself. See if they want to supply a ton of CBD for the Cdn market if you can find a market on the other side for it - they may just finance your inventory. I wonder what their margin is to give it to you where you can make yours, and still underprice CRDL?
<< Previous
Bullboard Posts
Next >>